Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.36 trillion and total revenue of $115.84 billion.
Market Cap
1.36T
Revenue
115.84B
Profits
-39.58B
PE Ratio
n/a
Profit Margin
-34.17%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.81B | 0.57% | 735,119 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 82.26B | 3.10% | 682,806 | 15.53B |
| 3 | ARGX | argenx SE | 64.25B | -0.31% | 192,945 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 61.59B | 9.93% | 25,831,744 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 44.98B | 2.09% | 1,834,261 | - |
| 6 | ONC | BeOne Medicines AG | 40.78B | -0.26% | 351,276 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 35.83B | 1.48% | 2,629,306 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.93B | 2.25% | 1,941,271 | 4.80B |
| 9 | INSM | Insmed Incorporated | 26.54B | -0.25% | 1,419,286 | 1.14B |
| 10 | BNTX | BioNTech SE | 25.61B | 0.33% | 1,040,117 | 3.03B |
| 11 | INCY | Incyte Corporation | 25.34B | 1.45% | 1,191,994 | 5.82B |
| 12 | ROIV | Roivant Sciences Ltd. | 24.93B | -0.35% | 6,906,003 | 7.53M |
| 13 | GMAB | Genmab A/S | 19.88B | 0.39% | 1,563,240 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 17.09B | -1.06% | 610,604 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.82B | -2.78% | 1,072,824 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.97B | -0.03% | 1,448,466 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 14.10B | 4.12% | 2,413,531 | 2.44B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 12.55B | -0.60% | 1,782,372 | 3.41B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.45B | -0.24% | 165,755 | 1.28B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.26B | 0.03% | 1,112,265 | 830.81M |
| 21 | HALO | Halozyme Therapeutics, Inc. | 12.23B | 1.16% | 1,058,737 | 1.66B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.69B | 0.42% | 1,330,721 | 669.50M |
| 23 | TECH | Bio-Techne Corporation | 11.32B | -0.18% | 2,903,320 | 1.22B |
| 24 | SMMT | Summit Therapeutics Inc. | 11.30B | 3.96% | 4,703,282 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 10.77B | 1.25% | 197,426 | 440.48M |
| 26 | ABVX | ABIVAX Société Anonyme | 10.68B | 1.74% | 991,486 | 5.67M |
| 27 | AXSM | Axsome Therapeutics, Inc. | 10.62B | 2.17% | 656,302 | 776.57M |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.19B | - | 1,090,742 | - |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | 9.95B | -0.80% | 1,872,594 | 874.09M |
| 30 | CYTK | Cytokinetics, Incorporated | 9.93B | 0.69% | 1,899,653 | 67.67M |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.90B | 0.20% | 576,626 | 105.00M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 9.87B | 0.90% | 305,832 | 7.46M |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 9.48B | -0.85% | 534,145 | 281.99M |
| 34 | PCVX | Vaxcyte, Inc. | 9.05B | 0.12% | 1,441,443 | - |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.01B | - | - | 42.16M |
| 36 | IBRX | ImmunityBio, Inc. | 8.34B | -1.01% | 6,465,675 | 165.79M |
| 37 | IMVT | Immunovant, Inc. | 8.24B | -2.25% | 1,585,489 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.96B | 3.30% | 3,198,319 | 799.54M |
| 39 | SYRE | Spyre Therapeutics, Inc. | 7.80B | -0.93% | 1,429,115 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.21B | -1.31% | 332,051 | 239.92M |
| 41 | CAI | Caris Life Sciences, Inc. | 7.00B | -2.79% | 4,027,434 | 989.61M |
| 42 | SRRK | Scholar Rock Holding Corporation | 6.81B | -1.60% | 763,187 | - |
| 43 | CGON | CG Oncology, Inc. | 6.72B | 0.93% | 876,134 | 6.23M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 6.39B | 0.30% | 398,380 | 618.07M |
| 45 | BLTE | Belite Bio, Inc | 6.31B | 0.64% | 114,136 | - |
| 46 | TVTX | Travere Therapeutics, Inc. | 6.19B | -0.86% | 1,074,583 | 591.33M |
| 47 | ORKA | Oruka Therapeutics, Inc. | 6.10B | -0.55% | 596,160 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 6.02B | -0.91% | 1,480,641 | - |
| 49 | DNTH | Dianthus Therapeutics, Inc. | 5.96B | 0.96% | 576,600 | 1.90M |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.89B | 1.47% | 691,015 | 1.01B |
| 51 | ERAS | Erasca, Inc. | 5.86B | -6.26% | 6,708,101 | - |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 5.81B | -0.37% | 418,794 | 7.50M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 5.67B | 0.06% | 185,017 | 290.54M |
| 54 | CRSP | CRISPR Therapeutics AG | 5.49B | -0.28% | 890,824 | 13.39M |
| 55 | DFTX | Definium Therapeutics, Inc. | 5.17B | -3.07% | 1,572,876 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.98B | -0.07% | 830,929 | 1.14B |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.88B | 1.18% | 500,168 | 148.00K |
| 58 | DYN | Dyne Therapeutics, Inc. | 4.69B | -1.30% | 1,629,389 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.59B | 1.15% | 1,040,507 | - |
| 60 | CELC | Celcuity Inc. | 4.50B | 3.28% | 1,161,861 | - |
| 61 | ELVN | Enliven Therapeutics, Inc. | 4.24B | -0.05% | 1,056,446 | - |
| 62 | LEGN | Legend Biotech Corporation | 4.09B | 1.68% | 1,463,470 | 1.27B |
| 63 | MANE | Veradermics, Incorporated | 4.07B | -0.91% | 548,759 | - |
| 64 | RLAY | Relay Therapeutics, Inc. | 4.05B | 0.60% | 1,598,443 | 10.35M |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.93B | 2.72% | 1,679,416 | - |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.85B | -0.37% | 587,802 | 234.13M |
| 67 | RCUS | Arcus Biosciences, Inc. | 3.78B | 1.47% | 1,528,495 | 117.00M |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.77B | -2.15% | 1,544,312 | 53.81M |
| 69 | IOVA | Iovance Biotherapeutics, Inc. | 3.75B | 1.35% | 6,760,745 | 324.97M |
| 70 | DNLI | Denali Therapeutics Inc. | 3.72B | -2.08% | 1,431,669 | 3.60M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.71B | -2.16% | 186,286 | 890.79M |
| 72 | ABCL | AbCellera Biologics Inc. | 3.66B | -1.74% | 4,251,145 | 66.17M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.36B | 2.66% | 816,627 | - |
| 74 | QURE | uniQure N.V. | 3.32B | -1.68% | 748,864 | 18.67M |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 3.25B | -0.26% | 587,273 | 606.33M |
| 76 | CLDX | Celldex Therapeutics, Inc. | 3.08B | -0.98% | 542,484 | 158.00K |
| 77 | IMNM | Immunome, Inc. | 3.07B | -1.26% | 700,168 | 4.02M |
| 78 | IRON | Disc Medicine, Inc. | 3.02B | 0.03% | 549,435 | - |
| 79 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | -0.92% | 1,101,734 | 463.98M |
| 80 | NAMS | NewAmsterdam Pharma Company N.V. | 2.98B | -1.66% | 714,358 | 7.12M |
| 81 | MBX | MBX Biosciences, Inc. | 2.93B | -1.09% | 416,086 | - |
| 82 | BEAM | Beam Therapeutics Inc. | 2.90B | -1.39% | 889,435 | 156.04M |
| 83 | ZLAB | Zai Lab Limited | 2.84B | -0.63% | 979,940 | 449.61M |
| 84 | ATAI | AtaiBeckley Inc. | 2.72B | - | 5,952,510 | 4.47M |
| 85 | NRIX | Nurix Therapeutics, Inc. | 2.70B | 1.01% | 1,597,357 | 36.77M |
| 86 | SLS | SELLAS Life Sciences Group, Inc. | 2.67B | -0.90% | 5,911,667 | - |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.61B | -0.56% | 998,384 | 71.13M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.54B | 2.38% | 1,872,067 | 717.00M |
| 89 | VERA | Vera Therapeutics, Inc. | 2.47B | 0.44% | 4,070,016 | - |
| 90 | PGEN | Precigen, Inc. | 2.46B | -1.01% | 2,806,113 | 85.72M |
| 91 | PHVS | Pharvaris N.V. | 2.45B | 0.92% | 394,435 | - |
| 92 | NKTR | Nektar Therapeutics | 2.45B | 0.52% | 334,105 | 54.59M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.40B | 4.75% | 894,900 | 959.90M |
| 94 | BHVN | Biohaven Ltd. | 2.38B | 3.08% | 2,480,254 | - |
| 95 | TRVI | Trevi Therapeutics, Inc. | 2.36B | -0.18% | 945,060 | - |
| 96 | NUVB | Nuvation Bio Inc. | 2.33B | -0.30% | 4,844,279 | 169.90M |
| 97 | RAPP | Rapport Therapeutics, Inc. | 2.33B | -0.23% | 148,596 | 20.00M |
| 98 | KOD | Kodiak Sciences Inc. | 2.32B | -0.78% | 391,609 | - |
| 99 | OCUL | Ocular Therapeutix, Inc. | 2.32B | 0.76% | 1,578,327 | 52.06M |
| 100 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | -0.39% | 728,424 | - |
| 101 | SRPT | Sarepta Therapeutics, Inc. | 2.25B | 1.43% | 2,623,726 | 1.97B |
| 102 | MESO | Mesoblast Limited | 2.20B | -1.55% | 169,082 | 120.25M |
| 103 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -1.34% | 119,939 | - |
| 104 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -0.37% | 878,852 | 311.51M |
| 105 | KLRA | Kailera Therapeutics, Inc. | 2.13B | 6.56% | 1,207,722 | - |
| 106 | URGN | UroGen Pharma Ltd. | 2.12B | 0.70% | 584,223 | 188.73M |
| 107 | ZYME | Zymeworks Inc. | 2.11B | 0.88% | 483,063 | 37.13M |
| 108 | ADMA | ADMA Biologics, Inc. | 2.09B | -0.64% | 1,756,180 | 512.28M |
| 109 | ZBIO | Zenas BioPharma, Inc. | 2.08B | -1.05% | 432,254 | 1.00M |
| 110 | XNCR | Xencor, Inc. | 2.08B | 2.35% | 1,475,981 | 104.97M |
| 111 | VCEL | Vericel Corporation | 2.07B | 1.50% | 651,115 | 306.30M |
| 112 | COAG | Hemab Therapeutics Holdings, Inc. | 2.06B | -3.74% | 318,514 | - |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 2.04B | 1.57% | 926,955 | 98.34M |
| 114 | GENB | Generate Biomedicines, Inc. | 2.03B | 3.41% | 1,048,822 | 26.48M |
| 115 | STOK | Stoke Therapeutics, Inc. | 1.99B | -0.99% | 727,504 | 27.59M |
| 116 | NBTX | Nanobiotix S.A. | 1.97B | -3.32% | 91,340 | 38.27M |
| 117 | VIR | Vir Biotechnology, Inc. | 1.97B | 6.31% | 2,778,729 | 303.23M |
| 118 | IMCR | Immunocore Holdings plc | 1.90B | 1.49% | 790,814 | 430.78M |
| 119 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.90B | -4.45% | 2,698,379 | 208.78M |
| 120 | GHRS | GH Research PLC | 1.88B | 1.41% | 464,909 | - |
| 121 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 0.18% | 149,042 | 1.13B |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.86B | 0.18% | 1,763,155 | 5.49M |
| 123 | INBX | Inhibrx Biosciences, Inc. | 1.83B | -1.61% | 275,907 | 1.30M |
| 124 | KARD | Kardigan, Inc. | 1.83B | -2.78% | 327,113 | - |
| 125 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 4.20% | 1,405,859 | 252.25M |
| 126 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -2.06% | 9,996,546 | 54.86M |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.78B | -0.35% | 2,184,156 | 59.51M |
| 128 | SEPN | Septerna, Inc. | 1.76B | -1.23% | 263,952 | 98.88M |
| 129 | DMRA | Damora Therapeutics, Inc. | 1.74B | -0.14% | 272,798 | - |
| 130 | BRVE | Braveheart Bio, Inc. | 1.69B | 3.06% | 342,869 | - |
| 131 | FTRE | Fortrea Holdings Inc. | 1.69B | -3.54% | 1,186,243 | 2.68B |
| 132 | NVAX | Novavax, Inc. | 1.67B | 8.00% | 10,040,575 | 413.80M |
| 133 | ANAB | AnaptysBio, Inc. | 1.64B | -3.07% | 773,856 | 232.39M |
| 134 | SLBT | SL Science Holding Limited | 1.59B | 2.20% | 7,841 | 3.27M |
| 135 | AVLN | Avalyn Pharma Inc. | 1.56B | 1.58% | 183,577 | - |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.55B | 1.30% | 429,860 | - |
| 137 | INVA | Innoviva, Inc. | 1.52B | 1.49% | 798,742 | 440.00M |
| 138 | LBRX | LB Pharmaceuticals Inc | 1.52B | -0.34% | 201,987 | - |
| 139 | ABSI | Absci Corporation | 1.52B | -2.21% | 3,241,899 | 1.56M |
| 140 | TYRA | Tyra Biosciences, Inc. | 1.51B | 1.08% | 423,513 | - |
| 141 | AAPG | Ascentage Pharma Group International | 1.51B | -5.09% | 7,072 | 94.61M |
| 142 | APMD | Apnimed, Inc. | 1.49B | 2.29% | 376,557 | 120.15M |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.49B | 0.33% | 356,093 | - |
| 144 | REPL | Replimune Group, Inc. | 1.48B | 2.42% | 1,778,984 | - |
| 145 | MAZE | Maze Therapeutics, Inc. | 1.47B | -0.15% | 326,661 | 20.00M |
| 146 | TRAX | First Tracks Biotherapeutics, Inc. | 1.47B | -1.60% | 557,548 | - |
| 147 | AKTS | Aktis Oncology, Inc. | 1.45B | 0.31% | 231,515 | 10.06M |
| 148 | LTGO | Latigo Biotherapeutics, Inc. | 1.41B | 1.09% | 288,898 | - |
| 149 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | -1.27% | 546,141 | - |
| 150 | ANRO | Alto Neuroscience, Inc. | 1.38B | -0.51% | 350,248 | - |
| 151 | MGTX | MeiraGTx Holdings plc | 1.36B | 2.75% | 880,480 | 397.50M |
| 152 | SVRA | Savara Inc. | 1.36B | -0.74% | 1,042,128 | - |
| 153 | OMER | Omeros Corporation | 1.36B | -0.21% | 2,042,703 | 38.42M |
| 154 | VOR | Vor Biopharma Inc. | 1.34B | 0.71% | 607,337 | - |
| 155 | JBIO | Jade Biosciences, Inc. | 1.34B | -1.59% | 516,639 | - |
| 156 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | -0.77% | 646,365 | - |
| 157 | IMTX | Immatics N.V. | 1.29B | -1.05% | 607,116 | 47.65M |
| 158 | DRTS | Alpha Tau Medical Ltd. | 1.29B | -1.06% | 465,407 | - |
| 159 | MLTX | MoonLake Immunotherapeutics | 1.29B | 0.53% | 662,549 | - |
| 160 | MNKD | MannKind Corporation | 1.28B | -0.75% | 2,234,753 | 393.63M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.26B | -0.30% | 122,757 | - |
| 162 | ALMS | Alumis Inc. | 1.23B | -56.58% | 28,399,012 | 7.40M |
| 163 | GLUE | Monte Rosa Therapeutics, Inc. | 1.22B | 2.65% | 796,289 | 28.73M |
| 164 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | 1.64% | 460,169 | - |
| 165 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | -0.08% | 172,831 | 99.00K |
| 166 | JANX | Janux Therapeutics, Inc. | 1.15B | 3.68% | 980,545 | 24.00M |
| 167 | KURA | Kura Oncology, Inc. | 1.15B | 1.90% | 1,513,391 | 77.23M |
| 168 | SANA | Sana Biotechnology, Inc. | 1.15B | -1.03% | 1,696,810 | - |
| 169 | IVA | Inventiva S.A. | 1.11B | 1.92% | 840,967 | 7.94M |
| 170 | SLDB | Solid Biosciences Inc. | 1.06B | 3.13% | 803,305 | - |
| 171 | AVTX | Avalo Therapeutics, Inc. | 1.02B | -2.02% | 606,643 | 59.00K |
| 172 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.20% | 2,610,125 | 181.72M |
| 173 | IMMX | Immix Biopharma, Inc. | 1.00B | -0.14% | 1,277,412 | - |
| 174 | CADL | Candel Therapeutics, Inc. | 983.26M | -1.68% | 935,642 | - |
| 175 | WVE | Wave Life Sciences, Inc. | 979.33M | 1.43% | 3,000,394 | 65.37M |
| 176 | LXRX | Lexicon Pharmaceuticals, Inc. | 974.45M | -2.67% | 1,987,900 | 41.47M |
| 177 | ATTO | Attovia Therapeutics, Inc. | 956.10M | 3.83% | 198,002 | 1.35M |
| 178 | GERN | Geron Corporation | 950.86M | -0.67% | 7,886,442 | 204.56M |
| 179 | DSGN | Design Therapeutics, Inc. | 947.49M | 0.33% | 476,964 | - |
| 180 | ARDX | Ardelyx, Inc. | 936.95M | -0.53% | 3,647,211 | 450.89M |
| 181 | ANNX | Annexon, Inc. | 927.04M | -1.01% | 1,472,606 | - |
| 182 | OLMA | Olema Pharmaceuticals, Inc. | 923.97M | 1.25% | 766,113 | - |
| 183 | SGP | SpyGlass Pharma, Inc. | 898.41M | 2.91% | 87,106 | - |
| 184 | FTH | Faeth Therapeutics, Inc. | 891.75M | 5.31% | 276,714 | - |
| 185 | SLN | Silence Therapeutics plc | 887.49M | 8.94% | 1,134,889 | 615.00K |
| 186 | RIGL | Rigel Pharmaceuticals, Inc. | 887.29M | 2.86% | 205,505 | 276.79M |
| 187 | ACRS | Aclaris Therapeutics, Inc. | 886.14M | -0.50% | 1,487,104 | 8.22M |
| 188 | TBPH | Theravance Biopharma, Inc. | 884.18M | -0.06% | 870,673 | 104.31M |
| 189 | ANL | Adlai Nortye Group Ltd. | 877.74M | -3.95% | 104,473 | 18.06M |
| 190 | CLYM | Climb Bio, Inc. | 851.21M | 7.94% | 1,972,572 | - |
| 191 | ACHV | Achieve Life Sciences, Inc. | 848.95M | 3.90% | 1,652,227 | - |
| 192 | HELP | Cybin Inc. | 847.50M | -1.36% | 1,140,718 | - |
| 193 | CTMX | CytomX Therapeutics, Inc. | 799.69M | 9.23% | 8,821,450 | 18.30M |
| 194 | PHAR | Pharming Group N.V. | 798.86M | -3.22% | 34,509 | 366.48M |
| 195 | DBVT | DBV Technologies S.A. | 794.50M | -2.89% | 250,611 | 5.04M |
| 196 | FDMT | 4D Molecular Therapeutics, Inc. | 792.75M | 1.70% | 707,964 | 92.01M |
| 197 | MNPR | Monopar Therapeutics Inc. | 789.15M | 5.04% | 95,175 | - |
| 198 | AURA | Aura Biosciences, Inc. | 770.53M | 3.48% | 534,541 | - |
| 199 | CBIO | Crescent Biopharma, Inc. | 767.42M | 8.01% | 788,171 | 11.88M |
| 200 | NGNE | Neurogene Inc. | 757.83M | 4.50% | 134,478 | 925.00K |
| 201 | OCS | Oculis Holding AG | 751.90M | -0.57% | 83,363 | 1.45M |
| 202 | NVCT | Nuvectis Pharma, Inc. | 751.33M | 1.45% | 176,925 | - |
| 203 | PHAT | Phathom Pharmaceuticals, Inc. | 745.85M | -1.88% | 885,493 | 239.66M |
| 204 | MPLT | MapLight Therapeutics, Inc. | 739.71M | 2.62% | 580,665 | - |
| 205 | OBX | Obsidian Therapeutics, Inc. | 738.28M | -2.68% | 79,264 | - |
| 206 | ASMB | Assembly Biosciences, Inc. | 716.29M | 4.61% | 301,100 | 74.85M |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 716.17M | 2.73% | 1,039,313 | 136.07M |
| 208 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 707.14M | 0.23% | 146,126 | - |
| 209 | DRUG | Bright Minds Biosciences Inc. | 693.29M | -1.24% | 65,838 | - |
| 210 | STTK | Shattuck Labs, Inc. | 689.50M | -2.00% | 639,618 | 1.00M |
| 211 | VSTM | Verastem, Inc. | 689.19M | 5.40% | 2,079,541 | 87.53M |
| 212 | GYRE | Gyre Therapeutics, Inc. | 686.04M | -1.52% | 54,547 | 109.82M |
| 213 | ALLO | Allogene Therapeutics, Inc. | 685.80M | -0.75% | 4,037,911 | 4.64M |
| 214 | AGMB | AgomAb Therapeutics NV | 666.82M | 2.81% | 241,315 | - |
| 215 | MDXG | MiMedx Group, Inc. | 658.84M | -0.44% | 762,367 | 355.17M |
| 216 | CRMD | CorMedix Inc. | 653.17M | 1.45% | 880,481 | 462.25M |
| 217 | SGMT | Sagimet Biosciences Inc. | 652.67M | 2.34% | 752,203 | - |
| 218 | OABI | OmniAb, Inc. | 645.53M | 1.37% | 1,156,203 | 38.46M |
| 219 | PRME | Prime Medicine, Inc. | 635.12M | -0.56% | 2,459,313 | 4.07M |
| 220 | CTNM | Contineum Therapeutics, Inc. | 622.63M | 1.91% | 212,119 | - |
| 221 | VALN | Valneva SE | 616.91M | 4.29% | 27,432 | 163.30M |
| 222 | RGNX | REGENXBIO Inc. | 615.24M | -1.89% | 783,802 | 174.48M |
| 223 | AUTL | Autolus Therapeutics plc | 614.84M | -1.70% | 1,477,729 | 117.39M |
| 224 | TECX | Tectonic Therapeutic, Inc. | 610.33M | 4.28% | 240,748 | - |
| 225 | ARVN | Arvinas, Inc. | 606.78M | 0.87% | 491,141 | 316.70M |
| 226 | ALT | Altimmune, Inc. | 601.06M | -0.64% | 2,355,222 | 31.00K |
| 227 | EIKN | Eikon Therapeutics, Inc. | 589.32M | 4.02% | 333,492 | - |
| 228 | CAPR | Capricor Therapeutics, Inc. | 581.97M | 1.01% | 6,308,556 | 11.13M |
| 229 | BLSM | BlossomHill Therapeutics, Inc. | 581.92M | 3.77% | 141,215 | - |
| 230 | SPRY | ARS Pharmaceuticals, Inc. | 573.81M | -3.83% | 1,358,006 | 116.93M |
| 231 | PRLD | Prelude Therapeutics Incorporated | 565.44M | -1.96% | 538,439 | 22.42M |
| 232 | CABA | Cabaletta Bio, Inc. | 559.50M | 6.11% | 6,647,981 | - |
| 233 | PROK | ProKidney Corp. | 559.30M | -2.12% | 695,726 | 818.00K |
| 234 | ARTV | Artiva Biotherapeutics, Inc. | 551.48M | -0.18% | 268,855 | 251.00K |
| 235 | SCTX | Scribe Therapeutics Inc. | 547.07M | -5.04% | 165,446 | 36.28M |
| 236 | ZURA | Zura Bio Limited | 541.43M | 1.99% | 1,104,980 | - |
| 237 | OVID | Ovid Therapeutics Inc. | 539.02M | 3.37% | 1,294,889 | 1.58M |
| 238 | KYTX | Kyverna Therapeutics, Inc. | 516.39M | -1.53% | 1,782,410 | - |
| 239 | ENTX | Entera Bio Ltd. | 502.11M | -1.69% | 256,682 | 42.00K |
| 240 | PRTA | Prothena Corporation plc | 493.35M | 2.78% | 267,670 | 54.53M |
| 241 | PBYI | Puma Biotechnology, Inc. | 482.65M | 2.63% | 458,304 | 231.24M |
| 242 | CCCC | C4 Therapeutics, Inc. | 476.11M | 4.31% | 2,364,277 | 35.04M |
| 243 | RLMD | Relmada Therapeutics, Inc. | 475.75M | 2.29% | 944,057 | - |
| 244 | EDIT | Editas Medicine, Inc. | 471.49M | 0.33% | 1,227,017 | 47.01M |
| 245 | RZLT | Rezolute, Inc. | 470.10M | -4.05% | 1,020,715 | - |
| 246 | DNA | Ginkgo Bioworks Holdings, Inc. | 466.67M | 1.76% | 1,810,570 | 132.42M |
| 247 | ARCT | Arcturus Therapeutics Holdings Inc. | 461.16M | 9.93% | 1,368,244 | 29.37M |
| 248 | VOGX | Vogenx, Inc. | 461.09M | -2.56% | 338,690 | - |
| 249 | EVMN | Evommune, Inc. | 452.93M | -1.42% | 278,492 | 10.00M |
| 250 | OCGN | Ocugen, Inc. | 451.02M | - | 2,180,898 | 4.58M |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 440.32M | 2.62% | 253,278 | - |
| 252 | IKT | Inhibikase Therapeutics, Inc. | 433.34M | 3.03% | 523,237 | 1.00 |
| 253 | QTTB | Q32 Bio Inc. | 427.49M | -3.43% | 331,608 | 53.74M |
| 254 | BNTC | Benitec Biopharma Inc. | 422.90M | 1.15% | 78,296 | - |
| 255 | FENC | Fennec Pharmaceuticals Inc. | 421.86M | -2.59% | 348,052 | 59.22M |
| 256 | GALT | Galectin Therapeutics Inc. | 420.54M | 5.57% | 479,583 | - |
| 257 | EPRX | Eupraxia Pharmaceuticals Inc. | 416.76M | -1.86% | 151,656 | - |
| 258 | CMPX | Compass Therapeutics, Inc. | 416.00M | -3.35% | 1,512,904 | 850.00K |
| 259 | LRMR | Larimar Therapeutics, Inc. | 411.27M | 3.14% | 755,350 | - |
| 260 | RCKT | Rocket Pharmaceuticals, Inc. | 409.46M | 0.27% | 948,754 | - |
| 261 | XFOR | X4 Pharmaceuticals, Inc. | 403.53M | 0.74% | 203,867 | 15.85M |
| 262 | VTVT | vTv Therapeutics Inc. | 396.97M | -0.16% | 52,700 | 36.84M |
| 263 | EYPT | EyePoint, Inc. | 394.85M | 1.78% | 3,261,201 | 2.79M |
| 264 | ENTA | Enanta Pharmaceuticals, Inc. | 393.48M | 1.35% | 217,296 | 65.26M |
| 265 | LXEO | Lexeo Therapeutics, Inc. | 385.60M | -1.26% | 420,477 | - |
| 266 | IPSC | Century Therapeutics, Inc. | 367.58M | -0.98% | 320,469 | 109.16M |
| 267 | AGEN | Agenus Inc. | 359.71M | 4.99% | 676,565 | 132.69M |
| 268 | UPB | Upstream Bio, Inc. | 358.75M | -1.06% | 476,487 | 3.16M |
| 269 | LYEL | Lyell Immunopharma, Inc. | 355.94M | 1.43% | 67,015 | 27.00K |
| 270 | ZNTL | Zentalis Pharmaceuticals, Inc. | 351.23M | -1.33% | 863,864 | 26.87M |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 347.82M | 1.57% | 145,931 | - |
| 272 | STRO | Sutro Biopharma, Inc. | 345.22M | 2.87% | 129,484 | 45.70M |
| 273 | ABEO | Abeona Therapeutics Inc. | 341.96M | 2.22% | 683,833 | 25.52M |
| 274 | PALI | Palisade Bio, Inc. | 341.57M | 0.51% | 879,448 | 500.00K |
| 275 | FHTX | Foghorn Therapeutics Inc. | 337.90M | -0.87% | 218,800 | 36.74M |
| 276 | SABS | SAB Biotherapeutics, Inc. | 336.65M | -0.27% | 202,282 | 114.70K |
| 277 | VNDA | Vanda Pharmaceuticals Inc. | 327.71M | 0.37% | 584,852 | 215.72M |
| 278 | IRD | Opus Genetics, Inc. | 318.64M | 5.80% | 868,853 | 9.86M |
| 279 | IFRX | InflaRx N.V. | 318.32M | 1.41% | 475,081 | -11.54K |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 314.03M | 0.28% | 7,683 | 412.09K |
| 281 | IMRX | Immuneering Corporation | 313.78M | -2.81% | 435,184 | - |
| 282 | PRQR | ProQR Therapeutics N.V. | 299.18M | -0.47% | 569,344 | 21.05M |
| 283 | CUVL | Clinuvel Pharmaceuticals Limited | 297.31M | 4.87% | 44,909 | 65.05M |
| 284 | FULC | Fulcrum Therapeutics, Inc. | 295.27M | -0.51% | 1,681,873 | 80.00M |
| 285 | OBIO | Orchestra BioMed Holdings, Inc. | 294.51M | -2.78% | 214,524 | 31.98M |
| 286 | TTRX | Turn Therapeutics Inc. | 292.52M | 2.29% | 43,211 | - |
| 287 | SION | Sionna Therapeutics, Inc. | 292.07M | 7.13% | 1,411,953 | - |
| 288 | FATE | Fate Therapeutics, Inc. | 291.16M | 1.67% | 1,041,343 | 6.49M |
| 289 | BCYC | Bicycle Therapeutics plc | 286.97M | -0.73% | 316,712 | 61.21M |
| 290 | PYXS | Pyxis Oncology, Inc. | 286.92M | 6.17% | 590,695 | 11.04M |
| 291 | RNAC | Cartesian Therapeutics, Inc. | 281.37M | 0.22% | 112,138 | 1.48M |
| 292 | ALXO | ALX Oncology Holdings Inc. | 273.79M | 2.59% | 1,441,610 | - |
| 293 | LCTX | Lineage Cell Therapeutics, Inc. | 273.14M | -1.82% | 905,661 | 13.08M |
| 294 | ALEC | Alector, Inc. | 267.98M | 6.19% | 482,394 | 13.86M |
| 295 | ACIU | AC Immune SA | 266.46M | 1.52% | 103,465 | 21.67M |
| 296 | AVXL | Anavex Life Sciences Corp. | 266.04M | 2.50% | 826,676 | - |
| 297 | YDES | YD Bio Limited | 265.46M | 1.75% | 428,666 | 510.36K |
| 298 | WHWK | Whitehawk Therapeutics, Inc. | 263.95M | 1.98% | 202,770 | 7.15M |
| 299 | SRZN | Surrozen, Inc. | 260.93M | 0.82% | 124,633 | 11.51M |
| 300 | IVVD | Invivyd, Inc. | 259.36M | -7.85% | 12,576,450 | 58.37M |
| 301 | MGNX | MacroGenics, Inc. | 257.35M | 1.25% | 499,895 | 175.14M |
| 302 | TRDA | Entrada Therapeutics, Inc. | 254.92M | 0.28% | 205,484 | 4.69M |
| 303 | NMRA | Neumora Therapeutics, Inc. | 249.90M | - | 532,617 | - |
| 304 | NGEN | NervGen Pharma Corp. | 249.45M | 4.98% | 1,057,789 | - |
| 305 | NAGE | Niagen Bioscience, Inc. | 248.19M | - | 282,997 | 129.08M |
| 306 | CGEN | Compugen Ltd. | 245.34M | 1.17% | 168,925 | 74.00M |
| 307 | ELDN | Eledon Pharmaceuticals, Inc. | 244.84M | 1.01% | 1,298,011 | - |
| 308 | ADAG | Adagene Inc. | 244.40M | 3.70% | 120,551 | 9.29M |
| 309 | CLLS | Cellectis S.A. | 240.19M | -1.49% | 9,822 | 63.82M |
| 310 | TNXP | Tonix Pharmaceuticals Holding Corp. | 239.77M | -0.85% | 498,210 | 29.10M |
| 311 | CAMP | Camp4 Therapeutics Corporation | 237.83M | -4.29% | 229,392 | 4.22M |
| 312 | RNA | Atrium Therapeutics, Inc. | 235.54M | 3.38% | 178,706 | 35.84M |
| 313 | TARA | Protara Therapeutics, Inc. | 230.47M | 1.04% | 222,411 | - |
| 314 | SLGL | Sol-Gel Technologies Ltd. | 227.61M | 0.61% | 130,156 | 1.80M |
| 315 | GLSI | Greenwich LifeSciences, Inc. | 220.32M | 0.40% | 98,695 | - |
| 316 | KROS | Keros Therapeutics, Inc. | 219.49M | -0.09% | 96,241 | 15.01M |
| 317 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 218.17M | 3.39% | 901,297 | - |
| 318 | PEPG | PepGen Inc. | 216.09M | 4.35% | 461,777 | - |
| 319 | NERV | Minerva Neurosciences, Inc. | 213.91M | -1.75% | 90,774 | - |
| 320 | CHRS | Coherus Oncology, Inc. | 211.67M | 1.48% | 695,157 | 50.94M |
| 321 | VYGR | Voyager Therapeutics, Inc. | 211.35M | -0.58% | 461,285 | 34.46M |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 211.17M | 2.46% | 188,968 | - |
| 323 | DTIL | Precision BioSciences, Inc. | 210.88M | - | 170,934 | 45.06M |
| 324 | PLX | Protalix BioTherapeutics, Inc. | 208.68M | 0.78% | 598,263 | 80.62M |
| 325 | ANTX | AN2 Therapeutics, Inc. | 206.79M | -1.26% | 215,424 | - |
| 326 | CUE | Cue Biopharma, Inc. | 206.60M | 11.44% | 177,425 | 37.66M |
| 327 | ORMP | Oramed Pharmaceuticals Inc. | 201.75M | -3.39% | 255,346 | 2.00M |
| 328 | NBP | NovaBridge Biosciences | 200.68M | -4.95% | 491,174 | - |
| 329 | ACOG | Alpha Cognition Inc. | 199.70M | -1.08% | 171,325 | 15.26M |
| 330 | IMUX | Immunic, Inc. | 198.94M | -7.72% | 230,232 | - |
| 331 | ARMP | Armata Pharmaceuticals, Inc. | 196.32M | -4.17% | 46,465 | 5.54M |
| 332 | MSLE | Satellos Bioscience Inc. | 196.13M | -2.78% | 3,497 | - |
| 333 | IPHA | Innate Pharma S.A. | 194.03M | -2.30% | 16,663 | 10.57M |
| 334 | NKTX | Nkarta, Inc. | 193.39M | -0.37% | 570,396 | - |
| 335 | CNTN | Canton Strategic Holdings, Inc. | 181.67M | - | 570,426 | 1.50M |
| 336 | KRRO | Korro Bio, Inc. | 180.24M | -2.00% | 59,005 | 2.38M |
| 337 | MENS | Jyong Biotech Ltd. | 168.51M | 1.79% | 15,260 | - |
| 338 | CRBU | Caribou Biosciences, Inc. | 166.17M | 0.65% | 756,280 | 10.04M |
| 339 | CDXS | Codexis, Inc. | 165.35M | -11.18% | 1,067,725 | 77.68M |
| 340 | LENZ | LENZ Therapeutics, Inc. | 164.33M | 0.38% | 605,583 | 21.48M |
| 341 | MDWD | MediWound Ltd. | 162.93M | 0.08% | 108,503 | 11.86M |
| 342 | MOLN | Molecular Partners AG | 161.45M | -4.78% | 968 | 856.30K |
| 343 | MIST | Milestone Pharmaceuticals Inc. | 160.64M | -1.72% | 1,019,980 | 2.34M |
| 344 | SPRB | Spruce Biosciences, Inc. | 159.80M | -5.71% | 58,131 | 697.00K |
| 345 | HUMA | Humacyte, Inc. | 158.46M | -5.15% | 16,536,117 | 2.12M |
| 346 | CNXU | Conexeu Sciences Inc. | 157.07M | -18.25% | 353,929 | - |
| 347 | TNYA | Tenaya Therapeutics, Inc. | 153.69M | -0.35% | 1,080,718 | 1.34M |
| 348 | OTLK | Outlook Therapeutics, Inc. | 151.69M | -1.63% | 3,579,939 | -1.16M |
| 349 | INDP | Indaptus Therapeutics, Inc. | 150.56M | -1.31% | 75,299 | - |
| 350 | NRXP | NRx Pharmaceuticals, Inc. | 148.82M | -1.15% | 392,760 | 3.39M |
| 351 | CNTB | Connect Biopharma Holdings Limited | 148.62M | 7.27% | 1,977,694 | 2.95M |
| 352 | KZIA | Kazia Therapeutics Limited | 144.32M | -8.28% | 612,196 | 1.27M |
| 353 | OKUR | OnKure Therapeutics, Inc. | 144.17M | -1.93% | 193,557 | - |
| 354 | UNCY | Unicycive Therapeutics, Inc. | 140.67M | -2.88% | 673,445 | - |
| 355 | EQ | Equillium, Inc. | 139.81M | -2.86% | 161,299 | 4.39M |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 137.52M | 4.72% | 2,630,623 | 65.34K |
| 357 | BMEA | Biomea Fusion, Inc. | 130.47M | 7.14% | 2,266,538 | - |
| 358 | AARD | Aardvark Therapeutics, Inc. | 129.56M | -2.95% | 85,009 | - |
| 359 | HURA | TuHURA Biosciences, Inc. | 129.37M | -4.69% | 152,902 | - |
| 360 | TLSA | Tiziana Life Sciences Ltd | 124.60M | -2.47% | 515,082 | - |
| 361 | ENGN | enGene Therapeutics Inc. | 124.27M | 0.82% | 657,378 | - |
| 362 | VANI | Vivani Medical, Inc. | 122.68M | -2.16% | 191,496 | - |
| 363 | RANI | Rani Therapeutics Holdings, Inc. | 120.51M | 1.25% | 1,155,898 | 4.88M |
| 364 | PMN | ProMIS Neurosciences, Inc. | 119.72M | 2.14% | 42,370 | - |
| 365 | CBUS | Cibus, Inc. | 119.23M | -3.70% | 139,484 | 4.35M |
| 366 | NAUT | Nautilus Biotechnology, Inc. | 117.90M | -4.72% | 570,988 | 190.00K |
| 367 | NTHI | NeOnc Technologies Holdings, Inc. | 117.57M | -4.25% | 96,550 | 39.99K |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 117.21M | -2.86% | 759,127 | 70.00M |
| 369 | GNLX | Genelux Corporation | 116.51M | -0.57% | 194,990 | 8.00K |
| 370 | GUTS | Fractyl Health, Inc. | 112.72M | -0.38% | 5,078,513 | 3.00K |
| 371 | ANIX | Anixa Biosciences, Inc. | 111.60M | -2.09% | 342,503 | - |
| 372 | PYPD | PolyPid Ltd. | 108.26M | 3.70% | 242,056 | - |
| 373 | SEER | Seer, Inc. | 107.42M | -1.02% | 411,463 | 14.22M |
| 374 | ONCY | Oncolytics Biotech Inc. | 107.11M | 0.21% | 435,918 | - |
| 375 | COYA | Coya Therapeutics, Inc. | 105.79M | -1.10% | 101,246 | 8.02M |
| 376 | TENX | Tenax Therapeutics, Inc. | 103.11M | -2.17% | 4,298,483 | - |
| 377 | ACET | Adicet Bio, Inc. | 99.68M | 6.44% | 134,127 | - |
| 378 | PLYX | Polaryx Therapeutics, Inc. | 98.70M | -1.49% | 87,141 | - |
| 379 | CGTX | Cognition Therapeutics, Inc. | 96.04M | -1.94% | 336,781 | - |
| 380 | RNXT | RenovoRx, Inc. | 95.22M | 9.33% | 3,313,665 | 1.98M |
| 381 | PTHS | Pelthos Therapeutics Inc. | 95.02M | 3.07% | 18,862 | 43.30M |
| 382 | KLRS | Kalaris Therapeutics, Inc. | 93.32M | -2.97% | 62,332 | - |
| 383 | ATRA | Atara Biotherapeutics, Inc. | 90.54M | 1.35% | 51,945 | 6.19M |
| 384 | ICCC | ImmuCell Corporation | 90.10M | 1.33% | 6,993 | 30.68M |
| 385 | VRCA | Verrica Pharmaceuticals Inc. | 90.02M | -4.03% | 43,491 | 30.32M |
| 386 | ALDX | Aldeyra Therapeutics, Inc. | 89.89M | 0.68% | 462,867 | - |
| 387 | DWTX | Dogwood Therapeutics, Inc. | 89.40M | 1.94% | 145,332 | - |
| 388 | FBIO | Fortress Biotech, Inc. | 89.38M | -2.01% | 605,781 | 68.47M |
| 389 | ACRV | Acrivon Therapeutics, Inc. | 88.71M | -0.96% | 356,517 | - |
| 390 | RLYB | Rallybio Corporation | 88.63M | -0.60% | 11,183 | 646.00K |
| 391 | YARW | Yarrow Bioscience, Inc. | 86.74M | -6.01% | 45,234 | - |
| 392 | GOSS | Gossamer Bio, Inc. | 81.83M | -1.53% | 7,323,396 | 53.29M |
| 393 | ATHE | Alterity Therapeutics Limited | 80.93M | 1.34% | 13,202 | 3.69M |
| 394 | CRDF | Cardiff Oncology, Inc. | 80.13M | 3.66% | 838,847 | 508.00K |
| 395 | OKYO | OKYO Pharma Limited | 79.24M | -0.66% | 22,267 | - |
| 396 | MAIA | MAIA Biotechnology, Inc. | 79.07M | -0.76% | 331,350 | - |
| 397 | GANX | Gain Therapeutics, Inc. | 77.25M | -1.67% | 197,910 | - |
| 398 | OSTX | OS Therapies Incorporated | 76.57M | -1.78% | 400,615 | - |
| 399 | TELO | Telomir Pharmaceuticals, Inc. | 75.65M | -1.79% | 19,566 | - |
| 400 | CING | Cingulate Inc. | 74.31M | -1.16% | 70,591 | - |
| 401 | NRXS | NeurAxis, Inc. | 72.96M | -3.33% | 59,556 | 5.32M |
| 402 | ANVS | Annovis Bio, Inc. | 72.00M | -1.74% | 457,633 | - |
| 403 | LONA | LeonaBio, Inc. | 71.51M | -4.17% | 154,385 | - |
| 404 | MNOV | MediciNova, Inc. | 70.88M | 0.35% | 19,971 | 920.48K |
| 405 | SPRO | Spero Therapeutics, Inc. | 69.88M | -1.64% | 385,398 | 47.00M |
| 406 | CSBR | Champions Oncology, Inc. | 69.47M | 0.10% | 2,050 | 59.43M |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 68.96M | 6.61% | 6,823,848 | - |
| 408 | PLRX | Pliant Therapeutics, Inc. | 68.73M | 0.91% | 267,480 | - |
| 409 | XBIT | XBiotech Inc. | 67.68M | -3.48% | 221,172 | - |
| 410 | ELTX | Elicio Therapeutics, Inc. | 67.28M | -5.19% | 334,838 | - |
| 411 | BOLD | Boundless Bio, Inc. | 65.74M | 2.85% | 146,028 | - |
| 412 | RNTX | Rein Therapeutics Inc. | 64.93M | 0.37% | 344,263 | - |
| 413 | ALPS | Alps Group Inc | 64.81M | -0.10% | 41,178 | 3.74M |
| 414 | EDSA | Edesa Biotech, Inc. | 64.59M | 0.95% | 24,180 | - |
| 415 | SER | Serina Therapeutics, Inc. | 63.50M | 3.31% | 32,638 | 130.00K |
| 416 | IBIO | iBio, Inc. | 62.59M | -0.79% | 2,233,663 | 100.00K |
| 417 | BSEM | BioStem Technologies, Inc. | 62.47M | -4.89% | 90,434 | 34.59M |
| 418 | INMB | INmune Bio Inc. | 62.17M | -2.61% | 206,153 | 50.00K |
| 419 | HYFT | MindWalk Holdings Corp. | 61.08M | -2.99% | 80,508 | 11.43M |
| 420 | ELOX | Eloxx Pharmaceuticals, Inc. | 60.59M | -10.49% | 34,079 | - |
| 421 | EXOZ | eXoZymes, Inc. | 60.33M | -3.42% | 4,129 | -700.00 |
| 422 | HRTX | Heron Therapeutics, Inc. | 59.80M | -0.94% | 2,375,177 | 151.18M |
| 423 | APLM | Apollomics, Inc. | 59.16M | -0.55% | 6,653 | 8.84M |
| 424 | XLO | Xilio Therapeutics, Inc. | 58.43M | -0.78% | 31,143 | 64.09M |
| 425 | IMA | ImageneBio, Inc. | 56.98M | -1.57% | 12,455 | 800.00K |
| 426 | INKT | MiNK Therapeutics, Inc. | 55.88M | -1.26% | 2,236 | - |
| 427 | CELU | Celularity Inc. | 54.42M | 1.62% | 1,622,080 | 26.55M |
| 428 | IMMP | Immutep Limited | 53.78M | 1.42% | 100,558 | 13.79M |
| 429 | NTRB | Nutriband Inc. | 52.82M | -0.50% | 18,657 | 1.80M |
| 430 | TIL | Instil Bio, Inc. | 52.15M | 1.05% | 11,900 | - |
| 431 | MCRB | Seres Therapeutics, Inc. | 51.50M | 5.50% | 49,169 | 1.88M |
| 432 | IBO | Impact BioMedical Inc. | 49.38M | -0.67% | 26,678 | 35.00K |
| 433 | HYPD | Hyperion DeFi, Inc. | 47.94M | -9.80% | 369,095 | 1.40M |
| 434 | ATYR | aTyr Pharma, Inc. | 46.74M | -10.38% | 1,173,067 | 190.00K |
| 435 | TVGN | Tevogen Inc. | 46.69M | 2.72% | 2,747 | - |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 46.53M | 1.75% | 982,574 | 21.00M |
| 437 | VERU | Veru Inc. | 45.87M | -3.93% | 203,192 | 16.89M |
| 438 | TCRX | TScan Therapeutics, Inc. | 45.16M | -8.69% | 820,279 | 7.11M |
| 439 | MGX | Metagenomi Therapeutics, Inc. | 44.20M | -0.85% | 239,768 | 13.56M |
| 440 | MREO | Mereo BioPharma Group plc | 44.19M | 3.71% | 1,560,764 | 500.00K |
| 441 | GRCE | Grace Therapeutics, Inc. | 44.18M | -1.41% | 78,968 | - |
| 442 | KPTI | Karyopharm Therapeutics Inc. | 41.96M | -10.19% | 1,598,052 | 146.62M |
| 443 | FLNA | Filana Therapeutics, Inc. | 41.41M | -4.53% | 217,299 | - |
| 444 | CRVO | CervoMed Inc. | 38.86M | -2.28% | 183,585 | 331.30K |
| 445 | ALGS | Aligos Therapeutics, Inc. | 38.03M | 3.92% | 101,645 | 31.52M |
| 446 | ACTU | Actuate Therapeutics, Inc. | 36.98M | 1.32% | 129,763 | - |
| 447 | VRXA | Veraxa Biotech AG | 35.30M | 3.70% | 384,802 | 29.54K |
| 448 | RNAZ | TransCode Therapeutics, Inc. | 34.88M | -1.90% | 98,171 | - |
| 449 | LITS | Lite Strategy, Inc. | 33.82M | 0.86% | 82,990 | - |
| 450 | CNTX | Context Therapeutics Inc. | 33.47M | -6.52% | 1,816,887 | - |
| 451 | QNCX | Quince Therapeutics, Inc. | 32.66M | -1.41% | 16,490 | - |
| 452 | KYNB | Kyntra Bio, Inc. | 32.19M | 2.19% | 27,581 | 4.62M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 31.61M | 1.11% | 109,455 | - |
| 454 | ATNM | Actinium Pharmaceuticals, Inc. | 31.30M | -2.40% | 30,067 | 35.09M |
| 455 | BRNS | Barinthus Biotherapeutics plc | 31.25M | 9.76% | 204,531 | 14.97M |
| 456 | NXTC | NextCure, Inc. | 31.13M | 6.42% | 112,895 | - |
| 457 | RADX | Radiopharm Theranostics Limited | 31.04M | -0.44% | 14,578 | 8.74M |
| 458 | IGC | IGC Pharma, Inc. | 30.67M | -0.84% | 775,864 | 1.11M |
| 459 | ESLA | Estrella Immunopharma, Inc. | 30.08M | -4.62% | 4,876 | - |
| 460 | CVM | CEL-SCI Corporation | 28.32M | -0.62% | 70,256 | - |
| 461 | NNVC | NanoViricides, Inc. | 27.56M | -3.20% | 204,023 | - |
| 462 | PLRZ | Polyrizon Ltd. | 26.88M | -1.03% | 276,189 | - |
| 463 | LTRN | Lantern Pharma Inc. | 25.82M | -0.49% | 199,488 | - |
| 464 | GRDX | GridAI Technologies Corp. | 25.35M | -3.76% | 20,957 | - |
| 465 | EVAX | Evaxion A/S | 24.85M | -0.67% | 63,035 | 7.49M |
| 466 | BYSI | BeyondSpring Inc. | 24.78M | -2.88% | 53,158 | 1.88M |
| 467 | QNTM | Quantum BioPharma Ltd. | 24.61M | -4.10% | 83,217 | - |
| 468 | ATOS | Atossa Therapeutics, Inc. | 24.15M | -3.20% | 92,004 | - |
| 469 | GNTA | Genenta Science S.p.A. | 23.83M | -0.98% | 30,154 | - |
| 470 | TVRD | Tvardi Therapeutics, Inc. | 23.28M | -3.06% | 96,831 | - |
| 471 | CLRB | Cellectar Biosciences, Inc. | 23.25M | -1.99% | 46,427 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 23.21M | -1.94% | 854,467 | - |
| 473 | ALLR | Allarity Therapeutics, Inc. | 22.59M | 0.71% | 54,102 | 345.00K |
| 474 | ENLV | Enlivex Ltd. | 22.38M | - | 343,342 | - |
| 475 | MRKR | Marker Therapeutics, Inc. | 21.68M | -2.26% | 21,028 | 3.55M |
| 476 | COCP | Cocrystal Pharma, Inc. | 21.57M | -3.45% | 34,756 | 330.00K |
| 477 | LGVN | Longeveron Inc. | 21.52M | -2.17% | 32,522 | 1.19M |
| 478 | ABVC | ABVC BioPharma, Inc. | 21.40M | -3.74% | 47,236 | 797.92K |
| 479 | LEXX | Lexaria Bioscience Corp. | 20.61M | 10.59% | 65,451 | 194.00K |
| 480 | CNSY | Cerenome, Inc. | 20.57M | -3.90% | 71,375 | 4.20M |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 20.48M | 0.80% | 20,827 | -13.27K |
| 482 | PTN | Palatin Technologies, Inc. | 20.34M | 15.52% | 149,149 | 12.88M |
| 483 | AKTX | Akari Therapeutics, Plc | 20.19M | -0.58% | 174,974 | - |
| 484 | CMMB | Chemomab Therapeutics Ltd. | 19.78M | 0.37% | 72,561 | - |
| 485 | NIKI | Niki BioSolutions, Inc. | 19.45M | -3.50% | 116,255 | - |
| 486 | DYAI | Dyadic International, Inc. | 19.39M | -4.14% | 398,489 | 3.80M |
| 487 | CYCN | Cyclerion Therapeutics, Inc. | 19.21M | 13.32% | 123,750 | 1.90M |
| 488 | NCEL | NewcelX Ltd. | 19.00M | 0.46% | 1,858 | - |
| 489 | LPCN | Lipocine Inc. | 18.96M | 2.68% | 10,017 | 1.57M |
| 490 | KTTA | Pasithea Therapeutics Corp. | 18.81M | -1.92% | 216,410 | - |
| 491 | BIVI | BioVie Inc. | 16.90M | -1.75% | 486,559 | - |
| 492 | TPST | Tempest Therapeutics, Inc. | 16.78M | -3.67% | 177,334 | - |
| 493 | PBM | Psyence Biomedical Ltd. | 16.67M | 0.69% | 17,591 | - |
| 494 | BCDA | BioCardia, Inc. | 16.65M | -3.51% | 69,292 | 3.00K |
| 495 | PLUR | Pluri Inc. | 15.75M | -0.68% | 3,676 | 1.08M |
| 496 | ADIL | Adial Pharmaceuticals, Inc. | 15.62M | 3.48% | 44,609 | - |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 15.62M | -1.91% | 226,556 | 7.11M |
| 498 | NRSN | NeuroSense Therapeutics Ltd. | 15.53M | -1.55% | 80,097 | - |
| 499 | HIND | Vyome Holdings, Inc. | 15.23M | 0.46% | 5,938 | 129.73K |
| 500 | MLEC | Moolec Science SA | 14.34M | 1.40% | 11,825 | 7.83M |